Crystalys Therapeutics Employee Directory

Crystalys Therapeutics corporate office is located in 12544 High Bluff Dr Ste 310, San Diego, California, 92130, United States and has 11-50 employees.

Employees by Department

Departments

Number of employees

C-Suite

2

Legal

2

Finance

1

Medical & Health

1

Operations

1

Key Employees of Crystalys Therapeutics

  • Justin Thacker, Chief Financial Officer at Crystalys Therapeutics
    United States flag for contact location.
    Justin Thacker

    Chief Financial Officer

    PhonePhoneEmailEmail
  • PhonePhoneEmailEmail
  • PhonePhoneEmailEmail
  • PhonePhoneEmailEmail
  • PhonePhoneEmailEmail
  • PhonePhoneEmailEmail

Crystalys Therapeutics Global Presence

globalPresence illustration
North America11-50

Index of contact profiles from Crystalys Therapeutics

Hundreds of professionals searching for Crystalys Therapeutics have connected with key decision-makers. Join them?
Contact Name
Contact Info
Job Title
HQ Location
12

People from Similar Companies in the Manufacturing Industry Located in California, United States

Frequently Asked Questions Regarding Crystalys Therapeutics Employees

How many employees does Crystalys Therapeutics have?
Crystalys Therapeutics has 11-50 employees
Who is the CFO of Crystalys Therapeutics?
Crystalys Therapeutics’s CFO is Justin Thacker
Who are Crystalys Therapeutics key employees?
Some of Crystalys Therapeutics key employees are Justin Thacker
Where is Crystalys Therapeutics located?
Crystalys Therapeutics’s headquarters are located at 12544 High Bluff Dr Ste 310, San Diego, California, 92130, United States
How do I contact Crystalys Therapeutics?
Crystalys Therapeutics Contact Info: Website: www.crystalystx.com
What does Crystalys Therapeutics do?

Based in San Diego, California, Crystalys Therapeutics is a clinical-stage biopharmaceutical company transforming the treatment of gout. Headquartered in San Diego, California, and co-founded by Catalys Pacific and Novo Holdings, Crystalys brings together a world-class team with deep expertise in gout drug development, dedicated to delivering more... effective options for people living with gout. The company's lead candidate, dotinurad, is a next-generation, once daily oral, URAT1 inhibitor in clinical development as a second-line therapy aimed to reduce uric acid, gout flares and tophi. Dotinurad was invented by Fuji Yakuhin and has obtained regulatory approval in Japan, China, Philippines and Thailand. With best-in-class potential for both safety and efficacy, dotinurad is supported by clinical data from multiple Asian markets where it is approved. Crystalys is advancing dotinurad in global Phase 3 trials toward regulatory approval and commercial launch.Read More

Is Crystalys Therapeutics a public company?
Crystalys Therapeutics is private company therefore does not currently have an official ticker symbol
See more information about Crystalys Therapeutics Employees

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.